\n Read it all
\n <\/a>\n <\/p>\n\n Col\u00f3n, in a round table with Carolina Aguilar, CEO of Inbrain Neuroelectronics, and Tim Knotnerus, CEO of Agomab Therapeutics, stated that per capita investment in treatments is much higher in the US. There has also been a decline in investment in research and development (R&D). “20 years ago in Europe we were first and now we are stagnating at 2.2% of GDP,” compared to over 3% in the US and 2.8% in China, she added.<\/p>\n
\n The president of AstraZeneca in Spain has also criticized “over-regulation”, which leads to a loss of competitiveness, just as the president of CaixaBank, Tom\u00e0s Muniesa, stated the previous day. For example, in Spain, the period for a drug to reach the market exceeds 500 days. <\/p>\n
\n AstraZeneca recently opened a global hub in Barcelona at the Estel building on Avinguda de Roma, where it will invest 1.3 billion euros until 2027 and 1,600 people dedicated to innovation work there. Col\u00f3n explained that the initiative had the collaboration of the administrations and that it brings an effect of attracting investments and revitalizing the neighborhood where it is located. She explained that the company received 60,000 job applications to join this project.<\/p>\n","protected":false},"excerpt":{"rendered":"You might be interested in El Ventorro: all the contradictions of a meal that has exposed Maz\u00f3n BarcelonaThe…\n","protected":false},"author":2,"featured_media":55187,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[20662],"tags":[11153,5961,634,27122,2401,22668,6843,2955,27121],"class_list":["post-55186","post","type-post","status-publish","format-standard","has-post-thumbnail","category-astrazeneca","tag-astrazeneca","tag-competitiveness","tag-european","tag-loss","tag-of","tag-pharmaceutical","tag-sector","tag-the","tag-warns"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@UnitedKingdom\/116685712121663282","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/britain\/wp-json\/wp\/v2\/posts\/55186","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/britain\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/britain\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/britain\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/britain\/wp-json\/wp\/v2\/comments?post=55186"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/britain\/wp-json\/wp\/v2\/posts\/55186\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/britain\/wp-json\/wp\/v2\/media\/55187"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/britain\/wp-json\/wp\/v2\/media?parent=55186"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/britain\/wp-json\/wp\/v2\/categories?post=55186"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/britain\/wp-json\/wp\/v2\/tags?post=55186"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}